A compound of formula (I), as well as its stereochemically isomeric forms and pharmaceutically acceptable acid addition salts, is disclosed. A process for preparing formula (I) involves the oxidation of a compound of formula (II) with a suitable oxidant in a reaction-inert solvent. The use of the compound is described to be in the manufacture of a medicament for treating a motility disorder of the intestinal system.
展开▼